Hadassah

Cell Cure Neurosciences Receives Grant of $1.33 Million From Israel's Office of the Chief Scientist

Wednesday, Aug 8 2012

Cell Cure Neurosciences Ltd., whose Chief Scientific Officer is Hadassah University Medical Center's Prof. Benjamin Reubinoff--Director of the its Human Embryonic Stem Cell Research Center--received a 1.3 million-dollar grant from Israel's Office of the Chief Scientist (OCS) to help finance its development of a treatment for age-related macular degeneration (AMD).

Cell Cure, established in 2005, manufactures diverse cell products, sourced from clinical-grade human embryonic stem cells. Its current programs include developing cells for the treatment of macular degeneration, Parkinson's disease, and cells potentially useful in treating multiple sclerosis. Cell Cure's plan for its cell-based product, OpRegen(R) includes filing an application to commence human clinical trials in 2013.

"We wish to thank the Office of the Chief Scientist for their participation in advancing this important new application of regenerative medicine," said Charles Irving, Chief Executive of Cell Cure. "We anticipate that OpRegen(R) will make a real difference in the quality of life of the aging population in many industrialized countries," he noted, "and hence it is a strategic investment for not only Israel, but the world as a whole."

AMD is a severe form of acute vision loss and the leading cause of blindness in older people. It affects that part of the retina which is most critical in everyday tasks, such as reading and recognizing faces. "I join with Dr. Irving in thanking OCS for its generous support in accelerating these advances in stem cell biology into the clinic," said Prof. Reubinoff.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Dec 8 2017

Israeli Start-Up Partners with Health Industry Leaders to Enhance Assessment of Head Trauma

MedyMatch Technology, an Israeli startup that has developed an artificial intelligence-based software to help clinicians more accurately assess head trauma or stroke...

READ MORE ›
alt_text

Friday, Dec 8 2017

Listening Beyond Eight Seconds

How long does the average doctor give a patient to tell her or him what’s wrong?

READ MORE ›
alt_text

Wednesday, Dec 6 2017

Hadassah and Australia Research Institute Sign MOU to Collaborate

A Memorandum of Understanding (MOU) to cooperate on scientific research in the fields of cardiovascular and diabetes medicine was signed on August 31 between the Hadassah Medical Organization and the Baker Heart and Diabetes Research Institute in Melbourne, Australia.

READ MORE ›
alt_text

Wednesday, Dec 6 2017

Hadassah’s Globally Renowned Ophthalmologist Receives International Recognition

Prof. Yaacov Pe’er, Immediate Past Director of the Hadassah Medical Organization’s Ophthalmology Department, has been honored with the American Academy of Ophthalmology (AAO)’s annual prize for his contributions to the field of ophthalmology and the prevention of blindness around the world.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More